What Is the Utility of ESR and CRP in the Evaluation of Acute IBD Presentations?

  • Richard T. GriffeyEmail author


Use of laboratory testing to predict complications of inflammatory bowel disease (IBD) is an enticing idea. Common targets for risk stratification tools include common markers of inflammation such as white blood cell count, erythrocyte sedimentation rate, and C-reactive protein. This chapter discusses the role of these markers in risk stratification for decision-making in the acute care setting.


C-reactive protein Erythrocyte sedimentation rate Crohn’s disease Emergency 


  1. 1.
    Fagan EA, Dyck RF, Maton PN, et al. Serum levels of C-reactive protein in Crohn’s disease and ulcerative colitis. Eur J Clin Investig. 1982;12:351–9.CrossRefGoogle Scholar
  2. 2.
    Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55:426–31.CrossRefGoogle Scholar
  3. 3.
    Alper A, Zhang L, Pashankar DS. Correlation of erythrocyte sedimentation rate and C-reactive protein with pediatric inflammatory bowel disease activity. J Pediatr Gastroenterol Nutr. 2017;65:e25–e7.CrossRefGoogle Scholar
  4. 4.
    Poullis AP, Zar S, Sundaram KK, et al. A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders. Eur J Gastroenterol Hepatol. 2002;14:409–12.CrossRefGoogle Scholar
  5. 5.
    Shine B, Berghouse L, Jones JE, Landon J. C-reactive protein as an aid in the differentiation of functional and inflammatory bowel disorders. Clin Chim Acta. 1985;148:105–9.CrossRefGoogle Scholar
  6. 6.
    Cappello M, Morreale GC. The role of laboratory tests in crohn’s disease. Clin Med Insights Gastroenterol. 2016;9:51–62.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041–8.CrossRefGoogle Scholar
  8. 8.
    Vilela EG, Torres HO, Martins FP, Ferrari Mde L, Andrade MM, Cunha AS. Evaluation of inflammatory activity in Crohn’s disease and ulcerative colitis. World J Gastroenterol. 2012;18:872–81.CrossRefGoogle Scholar
  9. 9.
    Kornbluth A, Sachar DB, Practice Parameters Committee of the American College of G. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501–23. quiz 24CrossRefGoogle Scholar
  10. 10.
    Dignass A, Eliakim R, Magro F, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis. 2012;6:965–90.CrossRefGoogle Scholar
  11. 11.
    Travis SP, Stange EF, Lemann M, et al. European evidence-based consensus on the management of ulcerative colitis: current management. J Crohns Colitis. 2008;2:24–62.CrossRefGoogle Scholar
  12. 12.
    Yarur AJ, Mandalia AB, Dauer RM, et al. Predictive factors for clinically actionable computed tomography findings in inflammatory bowel disease patients seen in the emergency department with acute gastrointestinal symptoms. J Crohns Colitis. 2014;8:504–12.CrossRefGoogle Scholar
  13. 13.
    Jung YS, Park DI, Hong SN, et al. Predictors of urgent findings on abdominopelvic CT in patients with crohn’s disease presenting to the emergency department. Dig Dis Sci. 2015;60:929–35.CrossRefGoogle Scholar
  14. 14.
    Govani SM, Guentner AS, Waljee AK, Higgins PD. Risk stratification of emergency department patients with Crohn’s disease could reduce computed tomography use by nearly half. Clin Gastroenterol Hepatol. 2014;12:1702–7. e3CrossRefGoogle Scholar
  15. 15.
    Abegunde AT. Computerized tomography of patients with Crohn’s disease in the emergency department: the more you look, the less you see. Clin Gastroenterol Hepatol. 2015;13:1706.CrossRefGoogle Scholar
  16. 16.
    Govani SM, Waljee AK, Kocher KE, Swoger JM, Saul M, Higgins PD. Validation of a tool predicting important findings on computed tomography among Crohn’s disease patients. United European Gastroenterol J. 2017;5:270–5.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Washington University School of MedicineSt. LouisUSA

Personalised recommendations